within Pharmacolibrary.Drugs.ATC.N;

model N05CD11
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 4.1666666666666665e-05,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.07,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.113,
    k12             = 2.1,
    k21             = 2.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05CD11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Loprazolam is a short-acting benzodiazepine hypnotic used for the short-term management of severe insomnia. It acts via enhancing GABAergic neurotransmission and has anxiolytic, sedative, and muscle relaxant properties. Though it was previously used in several countries for sleep disorders, its clinical use has diminished with the availability of safer alternatives, and it is not widely approved or marketed today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, single oral dose administration.</p><h4>References</h4><ol><li><p>Jochemsen, R, et al., &amp; Breimer, DD (1986). Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administration. <i>Biopharmaceutics &amp; drug disposition</i> 7(1) 53–61. DOI:<a href=\"https://doi.org/10.1002/bdd.2510070108\">10.1002/bdd.2510070108</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2869795/\">https://pubmed.ncbi.nlm.nih.gov/2869795</a></p></li><li><p>Swift, CG, et al., &amp; Robinson, J (1985). Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. <i>British journal of clinical pharmacology</i> 20(2) 119–128. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1985.tb05041.x\">10.1111/j.1365-2125.1985.tb05041.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2864049/\">https://pubmed.ncbi.nlm.nih.gov/2864049</a></p></li><li><p>Bareggi, SR, et al., &amp; Smirne, S (1988). Effect of after-dinner administration on the pharmacokinetics of oral flunitrazepam and loprazolam. <i>Journal of clinical pharmacology</i> 28(4) 371–375. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1988.tb03161.x\">10.1002/j.1552-4604.1988.tb03161.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3392235/\">https://pubmed.ncbi.nlm.nih.gov/3392235</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05CD11;
